As Leslie Kendrick of the University of Virginia School of Law explained recently on Torts Prof Blog, “state tort liability for design defect or failure-to-warn is predicated on a judgment that a drug or drug label was not designed safely. But (drugmakers) generally cannot alter drugs or labels without FDA approval. Thus, (drugmakers) argue, it is impossible for them to comply with both tort law and FDA requirements.”